Skip to content

Homoeopathic vs conventional treatment of Seborrheic dermatitis

Predefined Homoeopathic medicines vs Conventional medicine in treatment of Seborrheic dermatitis: A Pilot randomized clinical study. - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/062049
Enrollment
160
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L218- Other seborrheic dermatitis

Interventions

Intervention1: predefined homoeopathic medicine, oral antifungal allopathic medicine: Sulphur,Psorinum,Mezerum,Graphites,Arsenic album,Natrum muriaticum,Calcarea carbonicum,Kali sulphuricum,Sepia offi

Sponsors

Central council of research in Homoeopathy ,Janakpuri ,New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients 18-60 years 2.Both genders 3.Diagnosed cases of mild, moderate and severe SD 4.Patients who are willing to participate in the study and have given written informed consent. 5.Patients corresponding to the pre-identified homoeopathic medicines will be included in the study. 6.Patients not taking any allopathic treatment or using topical agents for SD from past 2weeks (wash out period) will be included in the study.

Exclusion criteria

Exclusion criteria: 1.SD cases suffering from chronic systemic illness inherited (acrodermatitis enteropathica) or acquired adult forms of zinc deficiency, alcoholic chronic pancreatitis, Diabetes, hepatitis C virus infection, nutritional deficiencies (eg riboflavin, pyridoxine, niacin, and essential fatty acids),central neurological and psychiatric disorders including parkinsonâ??s disease, tardive dyskinesia, depression, epilepsy, fascial nerve palsy, spinal cord injury and congenital disease such as Downâ??s syndrome, neuroleptic medications, psoriasis, psoralen plus ultraviolet A (PUVA) therapy. 2.Flexural seborrheic dermatitis in axilla, under breast, in groin folds and genital creases. 3.Doubtful cases and those with other concomitant dermatoses to be excluded. 4.Patients taking allopathic treatment or using topical agents for SD within past 2weeks will be excluded from the study. 5.Infants, pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
1.Seborrheic dermatitis area severity index score 2. Numerical rating score for itchingTimepoint: Baseline, every week upto 12 months

Secondary

MeasureTime frame
To outline the frequently indicated homoeopathic medicines in treatment of Seborrheic dermatitisTimepoint: after 12 months

Countries

India

Contacts

Public ContactDr Neha kalra

Central council of research in Homoeopathy

drnehamehta1985@gmail.com9810518111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026